Skip to main content
Clinical Trials/NCT07400874
NCT07400874
Not yet recruiting
Not Applicable

The Effects of Acupressure, Aromatherapy, and Virtual Reality on Pain, Fear, and Anxiety in Children During Blood Sampling Procedures

Artvin Coruh University0 sites120 target enrollmentStarted: March 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Artvin Coruh University
Enrollment
120
Primary Endpoint
1. Patient Identification Form

Overview

Brief Summary

This study aims to evaluate the effects of acupressure, music listening, and virtual reality applications, which appeal to the senses of touch, hearing, and sight during blood sampling, on pain, fear, and anxiety levels in children.

Detailed Description

Two hundred volunteer children aged 5-10 coming for blood collection will be randomly divided into four groups: acupressure, virtual reality, Listening music and control group. Children will be assessed before, during, and after the procedure. Pain related to blood collection will be assessed with the Wong-Baker Faces Pain Scale, fear will be assessed with the Child Fear Scale and anxiety will be assessed with the Child Anxiety Scale - State. In addition, children's demographic data will be recorded in the Information Form.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
5 Years to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Being between 5-10 years old Being healthy (no chronic disease diagnosis) Both child and parent agree to participate in the study Being able to communicate in Turkish Taking a blood sample in a single session Having no visual, auditory, or speech impairments, Being open to communication Being accompanied by a parent

Exclusion Criteria

  • Having an allergy to any substance Having a chronic illness (Type 1 diabetes, etc.) Having upper respiratory tract diseases such as asthma, rhinitis, pharyngitis Having an obstructive condition in the nasal passages for any reason Having vision or hearing loss Having any neuropathological problem Having complaints of vomiting, nausea, or pain Having recently used sedatives, anesthetics, or analgesics Having a chronic illness Having visual-auditory and speech impairments History of sedative, analgesic, or narcotic substance use within 24 hours prior to admission

Arms & Interventions

Control Group

No Intervention

Routine clinical care will be applied to the control group. No action will be taken.

Experimental Group

Experimental

Before blood is drawn, the child will undergo acupressure, watch a video through virtual reality glasses, and listen to music through headphones.

Intervention: Virtual Reality (Other)

Experimental Group

Experimental

Before blood is drawn, the child will undergo acupressure, watch a video through virtual reality glasses, and listen to music through headphones.

Intervention: Acupressure (Other)

Experimental Group

Experimental

Before blood is drawn, the child will undergo acupressure, watch a video through virtual reality glasses, and listen to music through headphones.

Intervention: Listening Music (Other)

Outcomes

Primary Outcomes

1. Patient Identification Form

Time Frame: Baseline

The form consists of a total of 7 questions covering the child's age, gender, previous hospital experience (if any), number of hospitalizations, whether their parents prepared them for blood tests beforehand, their experience with blood tests in the last six months, and their reactions to the blood test procedure.

Wong Baker Face Pain Scale

Time Frame: Baseline and up to 4 weeks

Children between the ages of three and eight can express many pain areas and their severity. In this study, the Wong-Baker Pain Inventory will be used in combination with the Visual Analog Scale, since face scales are more appropriate. The Wong Baker Face Pain Scale was developed by Donna Wong and Connie Moran Baker in 1981. The scale is suitable for children between the ages of three and eighteen. The scale includes facial expressions that the child can enjoy and enjoy. For this reason, it has been stated that it gives more accurate results. The scale has scores of "0", "2", "4", "6", "8", and "10". A score of "0" indicates no pain and a score of "10" indicates the highest pain. This scale does not have a Cronbach's alpha score. It has been reported that reliability studies have not been conducted on such scales.

3. Child Fear Scale

Time Frame: Baseline and up to 4 weeks

The Turkish validity of this scale, developed by McMurtry and colleagues, was done by Gerçeker and colleagues. The changes in the facial muscles of the frightened expression were drawn by a graphic artist from a photograph of a frightened face. It can be used by the parent, child or researcher to scale the child's fear. The scale, which has facial expressions scored from 0 to 4, is shown to the child. A score of 4 indicates that the child is very frightened, and a score of 0 indicates that the child is not frightened. It is accepted that a score of "0" indicates a neutral expression (no fear), a score of "1" indicates a very low level of fear, a score of "2" indicates a little fear, a score of "3" indicates a greater level of fear, and a score of 4 indicates that the level of fear is at the highest level. This scale can be used to measure fear before and during the procedure.

4. The Child Anxiety Scale-State (CAS-S)

Time Frame: Baseline and up to 4 weeks

Developed by Ersig et al. in 2013, the Child Anxiety Scale-State measures situational anxiety in children aged 4-10 years. Its validity was established by Gerçeker et al. in 2017. The CAS-S (State) is designed as a thermometer. At the bottom is a bulb, and horizontal lines extend upwards. Each horizontal line represents a score, and the thermometer has 10 points. The bulb at the bottom represents 0 points, indicating no anxiety. As the lines rise, anxiety increases. The peak, worth 10 points, represents the highest level of anxiety.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Artvin Coruh University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gamze Akay

Assistant Professor

Artvin Coruh University

Similar Trials